Patents by Inventor Samantha E. Wilner

Samantha E. Wilner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Programmed cargo release using nucleic acid-stabilized micelles
    Patent number: 10780051
    Abstract: Methods and compositions for serum-stabilizing micelles for drug delivery or imaging agent delivery are provided, as well as methods and compositions to enhance micelle-mediated drug delivery. This invention provides a process for synthesizing a lipid micelle comprising one or more lipid-oligonucleotide conjugate molecules, the process comprising contacting an amount of lipid molecules with an amount of lipid-oligonucleotide conjugate molecules sufficient to create a lipid micelle comprising lipid-oligonucleotide conjugate molecules.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: September 22, 2020
    Assignee: Albert Einstein College of Medicine
    Inventors: Samantha E. Wilner, Matthew Levy
  • PROGRAMMED CARGO RELEASE USING NUCLEIC ACID-STABILIZED MICELLES
    Publication number: 20170304200
    Abstract: Methods and compositions for serum-stabilizing micelles for drug delivery or imaging agent delivery are provided, as well as methods and compositions to enhance micelle-mediated drug delivery. This invention provides a process for synthesizing a lipid micelle comprising one or more lipid-oligonucleotide conjugate molecules, the process comprising contacting an amount of lipid molecules with an amount of lipid-oligonucleotide conjugate molecules sufficient to create a lipid micelle comprising lipid-oligonucleotide conjugate molecules.
    Type: Application
    Filed: October 7, 2015
    Publication date: October 26, 2017
    Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
    Inventors: Samantha E. Wilner, Matthew Levy
  • Transferrin receptor aptamers and aptamer-targeted delivery
    Patent number: 9439973
    Abstract: Aptamers targeted to a human transferrin receptor which do not compete with transferrin for binding are provided. Compositions and methods for aptamer-targeted liposomal drug delivery are also provided.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: September 13, 2016
    Assignee: Albert Einstein College of Medicine, Inc.
    Inventors: Matthew Levy, Keith Everett Maier, Samantha E. Wilner
  • TRANSFERRIN RECEPTOR APTAMERS AND APTAMER-TARGETED DELIVERY
    Publication number: 20150125516
    Abstract: Aptamers targeted to a human transferrin receptor which do not compete with transferrin for binding are provided. Compositions and methods for aptamer-targeted liposomal drug delivery are also provided.
    Type: Application
    Filed: April 24, 2013
    Publication date: May 7, 2015
    Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
    Inventors: Matthew Levy, Keith Everett Maier, Samantha E. Wilner